Cingulate Inc

NASDAQ:CING   3:26:59 PM EDT
1.16
+0.06 (+5.46%)
Earnings Announcements

Cingulate Reports Q1 2022 Results

Published: 05/12/2022 20:27 GMT
Cingulate Inc (CING) - Cingulate Inc. Reports First Quarter 2022 Results and Provides Clinical and Business Update.
Cingulate Inc- As of March 31, 2022, Cingulate Had $12.6 Million in Cash and Cash Equivalents.
Cingulate- Expects Cash, Cash Equivalents As of March 31, 2022, to Fund Research, Development, General, Administrative Expenditures Through Late 2022.
Cingulate Inc - Qtrly Loss per Share $0.44.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.64

More details on our Analysts Page.